Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Hug

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
European Journal of Radiology|May 7, 2020
Prediction of pathological complete response in breast cancer patients during neoadjuvant chemotherapy: Is shear wave elastography a useful tool in clinical routine?Anna Marie Maier, Jörg Heil, Aba Harcos, et al.
Breast Cancer Research and Treatment|October 27, 2019
Efficacy of intraoperative specimen radiography as margin assessment tool in breast conserving surgeryAnnika Funk, Jörg Heil, Aba Harcos, et al.
Breast Cancer Research and Treatment|October 1, 2011
CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancerFrederik Marmé, Wiebke Werft, Anne Walter, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
European Journal of Radiology|May 7, 2020
Prediction of pathological complete response in breast cancer patients during neoadjuvant chemotherapy: Is shear wave elastography a useful tool in clinical routine?Anna Marie Maier, Jörg Heil, Aba Harcos, et al.
Breast Cancer Research and Treatment|October 27, 2019
Efficacy of intraoperative specimen radiography as margin assessment tool in breast conserving surgeryAnnika Funk, Jörg Heil, Aba Harcos, et al.
Breast Cancer Research and Treatment|October 1, 2011
CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancerFrederik Marmé, Wiebke Werft, Anne Walter, et al.
Pageof 3